Literature DB >> 17017829

Metabolic syndrome and depression: a cross-sectional analysis.

Tuula H Heiskanen1, Leo K Niskanen, Jukka J Hintikka, Heli T Koivumaa-Honkanen, Kirsi M Honkalampi, Kaisa M Haatainen, Heimo T Viinamäki.   

Abstract

OBJECTIVE: To examine the prevalence of the metabolic syndrome in depressive outpatients and to identify its correlates in depression.
METHOD: This cross-sectional analysis was performed on 121 depressive outpatients from January 2002 through January 2004 who were diagnosed at baseline with the Structured Clinical Interview for DSM-III-R. The metabolic syndrome was diagnosed at 6-year follow-up according to the modified criteria of the National Cholesterol Education Program. The severity of depressive symptoms was assessed at follow-up with the Beck Depression Inventory and the Hamilton Rating Scale for Depression, and general psychopathology was assessed with the Symptom Checklist-90.
RESULTS: At 6-year follow-up, the prevalence of metabolic syndrome in the study group of depressive outpatients was 36% (N = 44). The syndrome was associated with a current diagnosis of major depression and overeating, but not with age or sex.
CONCLUSION: The metabolic syndrome is highly prevalent among patients with a history of depression, especially those with current major depression. This may have implications for treatment. Furthermore, attention should be focused on the physical health of those suffering from depression.

Entities:  

Mesh:

Year:  2006        PMID: 17017829     DOI: 10.4088/jcp.v67n0913

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  51 in total

Review 1.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

2.  The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients.

Authors:  Georgios Paslakis; Maria Gilles; Florian Lederbogen; Claudia Schilling; Barbara Scharnholz; Michael Deuschle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-30       Impact factor: 5.270

3.  Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition.

Authors:  Pauline M Maki; Ellen W Freeman; Gail A Greendale; Victor W Henderson; Paul A Newhouse; Peter J Schmidt; Nelda F Scott; Carol A Shively; Claudio N Soares
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

4.  [History and definition(s) of metabolic syndrome].

Authors:  M Hanefeld; F Schaper; A Ceriello
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

5.  Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms.

Authors:  Hua Jin; David Folsom; Alana Sasaki; Sunder Mudaliar; Robert Henry; Monique Torres; Shah Golshan; Danielle K Glorioso; Dilip Jeste
Journal:  Schizophr Res       Date:  2010-11-19       Impact factor: 4.939

6.  An exploration of the aversive properties of 2-deoxy-D-glucose in rats.

Authors:  Thomas Horman; Maria Fernanda Fernandes; Yan Zhou; Benjamin Fuller; Melissa Tigert; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2018-08-15       Impact factor: 4.530

7.  Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study.

Authors:  Kerry L Hildreth; Jim Grigsby; Lucinda L Bryant; Pamela Wolfe; Judith Baxter
Journal:  J Behav Med       Date:  2013-01-18

8.  Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome.

Authors:  Hua Jin; Nicole M Lanouette; Sunder Mudaliar; Robert Henry; David P Folsom; Srikriskna Khandrika; Danielle K Glorioso; Dilip V Jeste
Journal:  J Clin Psychopharmacol       Date:  2009-06       Impact factor: 3.153

9.  Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women.

Authors:  Edie M Goldbacher; Joyce Bromberger; Karen A Matthews
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

10.  Experienced poor lighting contributes to the seasonal fluctuations in weight and appetite that relate to the metabolic syndrome.

Authors:  Sharon Grimaldi; Ani Englund; Timo Partonen; Jari Haukka; Sami Pirkola; Antti Reunanen; Arpo Aromaa; Jouko Lönnqvist
Journal:  J Environ Public Health       Date:  2009-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.